Management of human keratomycosis with miconazole
- 1 August 1989
- journal article
- research article
- Published by Wiley in Australian and New Zealand Journal of Ophthalmology
- Vol. 17 (3), 295-297
- https://doi.org/10.1111/j.1442-9071.1989.tb00536.x
Abstract
A prospective clinical study was undertaken to evaluate the efficacy of 1% miconazole in 85 cases of smear-positive fungal corneal ulcers. Miconazole therapy healed 44 ulcers, thereby achieving a success rate of 64.7%. The most common organism encountered was Aspergillus followed by Fusarium, Phialophora and Candida. The average healing time was found to be 22 days. The drug was well tolerated by the eye and no symptoms of ocular toxicity were observed. The findings of this study suggest that miconazole is an effective agent for the management of human keratomycosis.Keywords
This publication has 10 references indexed in Scilit:
- Topical silver sulphadiazine--a new drug for ocular keratomycosis.British Journal of Ophthalmology, 1988
- SILVER SULFADIAZINE IN THE TREATMENT OF MYCOTIC KERATITIS1987
- EFFICACY OF MICONAZOLE IN EXPERIMENTAL KERATOMYCOSISAustralian and New Zealand Journal of Ophthalmology, 1986
- Ocular Toxicity of Topical Antifungal AgentsArchives of Ophthalmology (1950), 1981
- Miconazole Therapy for KeratomycosisAmerican Journal of Ophthalmology, 1981
- Spectrum of Microbial Keratitis in South FloridaAmerican Journal of Ophthalmology, 1980
- Intraocular Penetration of Miconazole in RabbitsArchives of Ophthalmology (1950), 1979
- Principles in the Management of Oculomycosis.American Journal of Ophthalmology, 1975
- KeratomycosisArchives of Ophthalmology (1950), 1971
- Mycotic Keratitis* *From the Division of Ophthalmology, College of Medicine, University of Florida. This work was supported in part by U.S.P.H.S. grants No. NB-04978 and NB-04977 from the National Institute of Neurological Diseases and Blindness.American Journal of Ophthalmology, 1965